Search results
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 17 hours agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit...
The Conversation· 1 hour agoEarlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. Combination < ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 3 days agoThe data are yet to be submitted for publication in a peer-reviewed journal, but the company says...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 10 hours agoWhat are the symptoms associated with KP.3? ... or runny nose Nausea or vomiting Diarrhea A new ...
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
Good Morning America via Yahoo News· 4 days agoModerna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels...
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 2 days agoModerna price target raised at Oppenheimer after RSV vaccine approval
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 12 hours agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoModerna will rival Pfizer and GSK, which launched their shots last year. Also, in June, Moderna and...
Combo COVID/flu vaccine elicits higher immune response in trial
UPI· 4 days agoThe new vaccine contains components of mRNA-1010, Moderna's vaccine candidate for seasonal...